User login
Key clinical point: Serum albumin levels at presentation may be a potential marker for COVID-19 severity and prognosis.
Major finding: Serum albumin of <3.5 g/dL was an independent risk factor for severe infection (adjusted odds ratio [aOR], 2.924; 95% confidence interval [CI], 1.509-5.664) and 30-day mortality (aOR, 2.615; 95% CI, 1.131-6.051).
Study details: A retrospective observational study included 296 patients with COVID-19 from emergency departments of 3 hospitals in Italy.
Disclosures: The study did not receive any funding. The authors declared no competing interests.
Source: Turcato G et al. Emerg Med J. 2021 Sep 21. doi: 10.1136/emermed-2020-210081.
Key clinical point: Serum albumin levels at presentation may be a potential marker for COVID-19 severity and prognosis.
Major finding: Serum albumin of <3.5 g/dL was an independent risk factor for severe infection (adjusted odds ratio [aOR], 2.924; 95% confidence interval [CI], 1.509-5.664) and 30-day mortality (aOR, 2.615; 95% CI, 1.131-6.051).
Study details: A retrospective observational study included 296 patients with COVID-19 from emergency departments of 3 hospitals in Italy.
Disclosures: The study did not receive any funding. The authors declared no competing interests.
Source: Turcato G et al. Emerg Med J. 2021 Sep 21. doi: 10.1136/emermed-2020-210081.
Key clinical point: Serum albumin levels at presentation may be a potential marker for COVID-19 severity and prognosis.
Major finding: Serum albumin of <3.5 g/dL was an independent risk factor for severe infection (adjusted odds ratio [aOR], 2.924; 95% confidence interval [CI], 1.509-5.664) and 30-day mortality (aOR, 2.615; 95% CI, 1.131-6.051).
Study details: A retrospective observational study included 296 patients with COVID-19 from emergency departments of 3 hospitals in Italy.
Disclosures: The study did not receive any funding. The authors declared no competing interests.
Source: Turcato G et al. Emerg Med J. 2021 Sep 21. doi: 10.1136/emermed-2020-210081.